SCI Pharmtech, Inc.
4119
Rank in Stocks
#17180
SCI Pharmtech, Inc., founded in 1987 and based in Taoyuan City, Taiwan,... SCI Pharmtech, Inc., founded in 1987 and based in Taoyuan City, Taiwan, specializes in the comprehensive lifecycle of pharmaceutical components. The company's core operations involve the research and development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs), chemical intermediates, and specialty chemicals. Its extensive portfolio of APIs includes critical compounds such as Articaine HCl, Atomoxetine HCl, Bisoprolol Fumarate, Brinzolamide, Cannabidiol, and Dexmethylphenidate HCl, among many others. Additionally, SCI Pharmtech produces a wide array of intermediate products, featuring substances like Azetidin-3-ol hydrogenchloride, Diethyl Isobutyl Malonate, Pyrogallolaldehyde, and various specialized esters and alcohols, which serve as essential building blocks in chemical synthesis. Beyond its standard product lines, the company also offers custom manufacturing services tailored to specific client needs. SCI Pharmtech maintains a robust international presence, distributing its products to significant markets across the globe, including Italy, China, the United States, Germany, Taiwan, Switzerland, Spain, Japan, and the Netherlands.
Share Price
$1.49
Last synced: 2026-11-10
Market Cap
$178.33M
Change (1 day)
-3.64%
Change (1 year)
-8.78%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade SCI Pharmtech, Inc. (4119)
Category
Healthcare
Operating Margin for SCI Pharmtech, Inc. (4119)
Operating Margin as of November 2026 TTM: 8.25%
According to SCI Pharmtech, Inc.'s latest financial reports, its current operating margin (TTM) is 8.25%. At the end of 2025 the company had an operating margin of 11.55%.
Operating Margin history for SCI Pharmtech, Inc. from 2009 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 8.25% | -28.57% |
| 2025 | 11.55% | -11.22% |
| 2024 | 13.01% | -2.25% |
| 2023 | 13.31% | -70.38% |
| 2022 | 44.94% | 513.10% |
| 2021 | 7.33% | -58.04% |
| 2020 | 17.47% | -41.65% |
| 2019 | 29.94% | 12.39% |
| 2018 | 26.64% | 47.75% |
| 2017 | 18.03% | -33.57% |
| 2016 | 27.14% | 11.73% |
| 2015 | 24.29% | 22.68% |
| 2014 | 19.80% | 24.37% |
| 2013 | 15.92% | -20.20% |
| 2012 | 19.95% | 11.27% |
| 2011 | 17.93% | -16.14% |
| 2010 | 21.38% | -9.79% |
| 2009 | 23.70% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -97.65% |
DE
|
|
| 19.68% | -97.61% |
DE
|
|
| 13.26% | -98.39% |
JP
|
|
| 17.08% | -97.93% |
CH
|
|
| 14.92% | -98.19% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about SCI Pharmtech, Inc.'s operating margin
What is SCI Pharmtech, Inc.'s operating margin?
SCI Pharmtech, Inc.'s operating margin is 8.25%, as of Nov 2026.
What was SCI Pharmtech, Inc.'s operating margin in 2025?
In 2025, SCI Pharmtech, Inc.'s operating margin was 11.55%, compared with 13.01% in 2024.
How has SCI Pharmtech, Inc.'s operating margin changed since 2020?
From 2020 to 2025, SCI Pharmtech, Inc.'s operating margin was highest in 2022 (44.94%) and lowest in 2021 (7.33%).
How does SCI Pharmtech, Inc.'s operating margin compare with similar companies?
SCI Pharmtech, Inc.'s operating margin (8.25%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.